These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8888087)

  • 21. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
    Paulzen M; Haen E; Hiemke C; Fay B; Unholzer S; Gründer G; Schoretsanitis G
    J Affect Disord; 2018 Feb; 227():506-511. PubMed ID: 29156365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desvenlafaxine succinate for major depressive disorder.
    Sproule BA; Hazra M; Pollock BG
    Drugs Today (Barc); 2008 Jul; 44(7):475-87. PubMed ID: 18806899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.
    Grözinger M; Dragicevic A; Hiemke C; Shams M; Müller MJ; Härtter S
    Pharmacopsychiatry; 2003 Jan; 36(1):3-6. PubMed ID: 12649767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.
    Matoga M; Pehourcq F; Titier K; Dumora F; Jarry C
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):213-8. PubMed ID: 11530979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of venlafaxine and O-desmethylvenlafaxine in a fatal case.
    Vignali C; Morini L; Chen Y; Stramesi C; Groppi A
    Forensic Sci Int; 2014 Sep; 242():e48-e51. PubMed ID: 25086830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype.
    Mannheimer B; Haslemo T; Lindh JD; Eliasson E; Molden E
    Ther Drug Monit; 2016 Feb; 38(1):127-34. PubMed ID: 26418700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepam.
    Troy SM; Lucki I; Peirgies AA; Parker VD; Klockowski PM; Chiang ST
    J Clin Pharmacol; 1995 Apr; 35(4):410-9. PubMed ID: 7650232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanol.
    Troy SM; Turner MB; Unruh M; Parker VD; Chiang ST
    J Clin Pharmacol; 1997 Nov; 37(11):1073-81. PubMed ID: 9506002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.
    Homero de Souza Filho J; Bonifácio FN; Bedor DC; Ramos VL; de Sousa CE; Sardón LL; Gonçalves TM; Moreira RC; Leal LB; de Santana DP
    Clin Ther; 2010 Nov; 32(12):2088-96. PubMed ID: 21118744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers.
    Fukuda T; Yamamoto I; Nishida Y; Zhou Q; Ohno M; Takada K; Azuma J
    Br J Clin Pharmacol; 1999 Apr; 47(4):450-3. PubMed ID: 10233212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
    Preskorn S; Patroneva A; Silman H; Jiang Q; Isler JA; Burczynski ME; Ahmed S; Paul J; Nichols AI
    J Clin Psychopharmacol; 2009 Feb; 29(1):39-43. PubMed ID: 19142106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of the dual mechanisms of action of venlafaxine.
    Harvey AT; Rudolph RL; Preskorn SH
    Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A.
    Tozatto E; Benzi JRL; Rocha A; Coelho EB; Lanchote VL
    J Clin Pharmacol; 2021 Mar; 61(3):319-327. PubMed ID: 32974907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid high-performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of venlafaxine and O-desmethylvenlafaxine in human plasma and its application in comparative bioavailability study.
    Rajasekhar D; Kumar IJ; Venkateswarlu P
    Biomed Chromatogr; 2009 Dec; 23(12):1300-7. PubMed ID: 19517423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clarification of venlafaxine chemistry, pharmacology, and pharmacokinetics.
    Albano D; Amchin J
    Am J Health Syst Pharm; 1995 Jul; 52(14):1573-4. PubMed ID: 7552908
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.
    Hynninen VV; Olkkola KT; Bertilsson L; Kurkinen K; Neuvonen PJ; Laine K
    Clin Pharmacol Ther; 2008 Feb; 83(2):342-8. PubMed ID: 17687273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI.
    Sigurdsson HP; Hefner G; Ben-Omar N; Köstlbacher A; Wenzel-Seifert K; Hiemke C; Haen E
    J Neural Transm (Vienna); 2015 May; 122(5):721-9. PubMed ID: 25257248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.